Works matching IS 00099236 AND DT 2003 AND VI 73 AND IP 5

Results: 13

Drug therapy in the elderly: Improving quality and access.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 387, doi. 10.1016/S0009-9236(03)00011-0
By:
- Simon, Steven R.;
- Gurwitz, Jerry H.
Publication type:
Article
'Inactive' excipients such as Cremophor can affect in vivo drug disposition.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 394, doi. 10.1016/S0009-9236(03)00010-9
By:
- Wandel, Cristoph;
- Kim, Richard B.;
- Stein, C. Michael
Publication type:
Article
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 397, doi. 10.1016/S0009-9236(03)00059-6
By:
- Tayrouz, Yorki;
- Ding, Reinhard;
- Burhenne, Jürgen;
- Riedel, Klaus-Dieter;
- Weiss, Johanna;
- Hoppe-Tichy, Torsten;
- Haefeli, Walter Emil;
- Mikus, Gerd
Publication type:
Article
Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 406, doi. 10.1016/S0009-9236(03)00006-7
By:
- Washington, Carla B.;
- Flexner, Charles;
- Sheiner, Lewis B.;
- Rosenkranz, Susan L.;
- Segal, Yoninah;
- Aberg, Judith A.;
- Blaschke, Terrence F.
Publication type:
Article
Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 417, doi. 10.1016/S0009-9236(03)00008-0
By:
- Tegeder, Irmgard;
- Bräutigam, Lutz;
- Seegel, Maic;
- Al-Dam, Ahmed;
- Turowski, Bernd;
- Geisslinger, Gerd;
- Kovács, Adorján F.
Publication type:
Article
Characterization of hepatic cytochrome P4503A activity in patients with end-stage renal disease*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 427, doi. 10.1016/S0009-9236(03)00056-0
By:
- Dowling, Thomas C.;
- Briglia, Andrew E.;
- Fink, Jeffrey C.;
- Hanes, Donna S.;
- Light, Paul D.;
- Stackiewicz, Lucy;
- Karyekar, Chetan S.;
- Eddington, Natalie D.;
- Weir, Matthew R.;
- Henrich, William L.
Publication type:
Article
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 435, doi. 10.1016/S0009-9236(03)00014-6
By:
- Watanabe, Ichiro;
- Tomita, Aiko;
- Shimizu, Miho;
- Sugawara, Mie;
- Yasumo, Hiroaki;
- Koishi, Ryuta;
- Takahashi, Tohru;
- Miyoshi, Kaoru;
- Nakamura, Kouichi;
- Izumi, Takashi;
- Matsushita, Yasuyuki;
- Furukawa, Hidehiko;
- Haruyama, Hideyuki;
- Koga, Teiichiro
Publication type:
Article
Coordinated intrahepatic and extrahepatic regulation of cytochrome P4502D6 in healthy subjects and in patients after liver transplantation*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 456, doi. 10.1016/S0009-9236(03)00055-9
By:
- Carcillo, Joseph A.;
- Adedoyin, Adedayo;
- Burckart, Gilbert J.;
- Frye, Reginald F.;
- Venkataramanan, Raman;
- Knoll, Carmela;
- Thummel, Kenneth;
- Roskos, Lorin;
- Wilson, John W.;
- Sereika, Susan;
- Romkes, Marjorie;
- Bebia, Zourab;
- Branch, Robert A.
Publication type:
Article
Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 468, doi. 10.1016/S0009-9236(03)00013-4
By:
- Obase, Yasushi;
- Shimoda, Terufumi;
- Kawano, Tetsuya;
- Saeki, Sachiko;
- Tomari, Shin-ya;
- Mitsuta-Izaki, Kazuko;
- Matsuse, Hiroto;
- Kinoshita, Moritoshi;
- Kohno, Shigeru
Publication type:
Article
Response to 'The efficacy of simvastatin is not influenced by CYP2D6 polymorphism' by Geisel et al.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 475, doi. 10.1016/S0009-9236(03)00054-7
By:
- Mulder, A. B.;
- van den Bergh, F. A. J. T. M.;
- Vermes, I.
Publication type:
Article
Cytochrome P4502C9 activity in end-stage renal disease*.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 475, doi. 10.1016/S0009-9236(03)00015-8
By:
- Dreisbach, Albert W.;
- Japa, Shanker;
- Gebrekal, Aster B.;
- Mowry, Sarah E.;
- Lertora, Juan J. L.;
- Kamath, Burde L.;
- Rettie, Allan E.
Publication type:
Article
The need to consider the cost factor of drugs in clinical trials.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 477, doi. 10.1016/S0009-9236(03)00064-X
By:
- Reidenberg, June W.
Publication type:
Article
A MESSAGE FROM THE ASCPT MEMBERSHIP COMMITTEE CHAIRPERSON.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 479, doi. 10.1016/S0009-9236(03)00061-4
By:
- Kroetz, Deanna L.
Publication type:
Article

Works matching IS 00099236 AND DT 2003 AND VI 73 AND IP 5

Drug therapy in the elderly: Improving quality and access.

'Inactive' excipients such as Cremophor can affect in vivo drug disposition.

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40<sup>*</sup>.

Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors<sup>*</sup>.

Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer<sup>*</sup>.

Characterization of hepatic cytochrome P4503A activity in patients with end-stage renal disease<sup>*</sup>.

A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

Coordinated intrahepatic and extrahepatic regulation of cytochrome P4502D6 in healthy subjects and in patients after liver transplantation<sup>*</sup>.

Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma.

Response to 'The efficacy of simvastatin is not influenced by CYP2D6 polymorphism' by Geisel et al.

Cytochrome P4502C9 activity in end-stage renal disease<sup>*</sup>.

The need to consider the cost factor of drugs in clinical trials.

A MESSAGE FROM THE ASCPT MEMBERSHIP COMMITTEE CHAIRPERSON.